SC upholds SAT relief in Biocon insider trading case

SC upholds SAT relief in Biocon insider trading case. The Supreme Court has upheld the Securities Appellate Tribunal's decision to grant relief to a former Biocon executive in an insider trading case. This reaffirms the lower tribunal’s findings, though no penalty or market-moving financial outcome was imposed on the company. The ruling is seen as a legal clarification rather than a financial risk.
📊 STOCKS: BIOCON | 🏢 SECTOR: Pharma | #LOWIMPACT #Legal